Resveratrol for Blood Sugar: What Human Trials Show
Resveratrol has shown lower blood sugar markers in some trials of people with type 2 diabetes, but the evidence is not consistent. Small studies, short follow-up and large differences between trials keep the certainty low. In healthy or overweight adults without diabetes, the better-controlled trials mostly show no change in insulin sensitivity. This article sets out what the studies measured, what they found, which doses were used and where the limits are.
TL;DR
- A Cochrane review found neutral results for fasting glucose, HbA1c and insulin resistance in adults with type 2 diabetes, based on three small, short trials.
- A 2014 meta-analysis reported lower glucose and insulin markers in people with diabetes, but not in people without diabetes, with high variation between studies.
- A Dutch 6-month trial in overweight adults found no difference from placebo in insulin sensitivity.
- Resveratrol is not a replacement for prescribed diabetes care. Speak to a GP or pharmacist before combining it with medicines.
Table of Contents
- What blood sugar markers the studies measure
- Does resveratrol lower blood sugar in type 2 diabetes?
- Resveratrol and insulin sensitivity in adults without diabetes
- Doses and treatment periods in the research
- Safety and medicine interactions
- Can resveratrol replace diabetes care?
- Our perspective
- Choosing a resveratrol supplement
- What good blood sugar habits look like
- FAQ
- Sources
What blood sugar markers the studies measure
Four measures appear again and again in resveratrol research. Knowing them makes the results easier to read.
- Fasting glucose: blood sugar after an overnight fast. Reported in mg/dL or mmol/L.
- HbA1c: the average blood sugar over roughly two to three months. In the Netherlands it is reported in mmol/mol.
- Fasting insulin: how much insulin the body needs to keep glucose in range.
- HOMA-IR and the Matsuda index: calculated scores of insulin resistance and insulin sensitivity. A lower HOMA-IR suggests better sensitivity. A higher Matsuda index suggests better sensitivity.
Type 2 diabetes involves insufficient insulin production and/or reduced sensitivity of cells to insulin, as Voedingscentrum explains in its guidance on type 2 diabetes. The same page names healthy eating based on the Schijf van Vijf as a foundation of care. Any supplement sits on top of that, not in place of it.
Does resveratrol lower blood sugar in type 2 diabetes?
The answer depends on which review is read.
The cautious view: Cochrane
The Cochrane review on resveratrol in adults with type 2 diabetes found only three randomised trials with 50 adults. Doses were 10 mg, 150 mg or 1,000 mg daily for 4 to 5 weeks. Results for fasting glucose, HbA1c and insulin resistance were neutral. For fasting glucose, two studies with 31 participants gave a mean difference of 2 mg/dL against placebo, with a confidence interval from −2 to 7. That interval covers no effect. The authors rated certainty as very low and concluded that evidence was insufficient to judge either benefit or harm.
The more positive view: meta-analyses
Meta-analyses that pool more trials report larger effects.
- A 2014 meta-analysis in the American Journal of Clinical Nutrition covered 11 trials and 388 participants. In participants with diabetes it reported pooled differences of −35.22 mg/dL for fasting glucose, −4.55 μIU/mL for fasting insulin, −0.79 percentage points for HbA1c and −2.25 for HOMA-IR. It found no significant effects in participants without diabetes. It also reported substantial differences between studies and called for larger, higher-quality trials longer than 3 months.
- A 2021 systematic review and meta-analysis reported lower fasting glucose with a weighted mean difference of −19.61 mg/dL. Heterogeneity was around 85%, which means the trials disagreed widely with each other.
- A 2022 review on age and dose reported dose- and age-dependent reductions in glucose, HbA1c and insulin. Its authors still concluded that evidence was insufficient to recommend a therapeutic dose.
How to read the gap
Pooled results can look impressive while the underlying trials are small, short and different in design. When the heterogeneity is as high as 85%, the average hides a wide spread: some trials show a clear drop, others show none. That is why the Cochrane team, which applied stricter criteria, found the certainty very low. The US National Center for Complementary and Integrative Health summary on type 2 diabetes and supplements takes a similar line: low-certainty evidence for glycaemic control, and more research needed before firm conclusions.
| Source | Population | What it reported | Caution |
|---|---|---|---|
| Cochrane (2020) | 50 adults with type 2 diabetes, 3 trials | Neutral for fasting glucose, HbA1c, insulin resistance | Very low certainty, 4 to 5 weeks only |
| AJCN meta-analysis (2014) | 388 participants, 11 trials | Lower glucose, insulin, HbA1c, HOMA-IR in diabetes; no effect without diabetes | Substantial heterogeneity |
| Systematic review (2021) | Randomised trials | Fasting glucose −19.61 mg/dL | I² about 85% |
| Age and dose review (2022) | Randomised trials | Dose- and age-dependent reductions | No therapeutic dose can be recommended |
Resveratrol and insulin sensitivity in adults without diabetes
Many readers are not asking about diabetes. They are adults over 40 who want to keep their metabolism healthy. For them the direct measurements of insulin sensitivity matter most.
The Dutch 6-month trial
A randomised trial from the Netherlands, published in 2020, gave 150 mg of resveratrol a day for 6 months to 41 overweight adults aged 40 to 70. The Matsuda index, a direct measure of insulin sensitivity, did not differ from placebo (5.18 versus 5.50). Fasting glucose, fasting insulin and the glucose and insulin responses were also unchanged.
HbA1c was lower in the resveratrol group, at 35.8 versus 37.6 mmol/mol. That is an interesting signal, but it should not be treated as proof of better insulin sensitivity when the direct measure did not move. HbA1c can shift for several reasons.
Postmenopausal women
A randomised trial indexed on PubMed in 2012 gave 75 mg a day for 12 weeks to nonobese postmenopausal women with normal glucose tolerance. Insulin sensitivity in the liver, skeletal muscle and adipose tissue did not improve.
What this suggests
Taken together with the 2014 meta-analysis, the pattern is consistent: any benefit looks concentrated in people whose glucose control is already impaired, and is hard to find in people with healthy glucose handling. This does not prove resveratrol does nothing in other groups. It means the trials so far have not shown it.
Doses and treatment periods in the research
Doses in the trials vary a great deal, which is one reason results are hard to compare.
- 10 mg a day and 1,000 mg a day, both for 4 to 5 weeks, appear among the Cochrane trials, along with 150 mg a day.
- 75 mg a day for 12 weeks was used in the postmenopausal women study.
- 150 mg a day for 6 months was used in the Dutch trial.
The 2014 meta-analysis noted that longer trials are needed, and the 2022 review found no dose that could be recommended for therapeutic use. A reader cannot take a dose from these studies and expect a known effect on blood sugar.
Timing with food is a practical question. Our article on resveratrol with food looks at a 400 mg study in which a meal delayed the peak to around 2 hours. Absorption details matter when trials use different protocols.
Safety and medicine interactions
NCCIH’s evidence summary warns of interactions with medicines, especially anticoagulant and antiplatelet drugs. People who take medicines for diabetes should treat resveratrol as something to discuss first, not add alone. If blood sugar is already treated, a change in glucose could affect how a medicine works. The people to speak to are the GP, the diabetes nurse or the pharmacist.
Some points for the conversation:
- Bring the product label with the dose per capsule.
- Name every medicine, including blood thinners and any glucose-lowering tablets.
- Ask whether and how often blood sugar should be monitored if a supplement is started.
For a wider look at tolerability, see our overview of resveratrol side effects and safety limits.
Can resveratrol replace diabetes care?
No. Cochrane found insufficient evidence to assess resveratrol’s efficacy or safety for treating type 2 diabetes. Nothing in the trials supports stopping or reducing prescribed treatment, a diet plan or physical activity. Changes to medicines belong with the treating doctor.
Our perspective
We read the evidence on resveratrol and blood sugar as promising in places and unproven overall. The pooled results in people with diabetes are interesting. The best-controlled trials in people without diabetes, including the Dutch 6-month study, show no gain in insulin sensitivity. We do not describe resveratrol as a way to lower blood sugar, and we would not want a customer to buy it for that reason.
What we do care about is a clear formulation and honest context. Vivetus supplements are vegan, GMO-free and assembled in the Netherlands, with ingredients that have clinical research behind them. Resveratrol is one of several compounds in the range that are studied in the context of healthy aging. For metabolism, the trial data for berberine in adults with insulin resistance over 8 to 12 weeks is a separate body of evidence, and we cover it on its own terms. Readers who want to see how resveratrol is studied in aging biology can read about resveratrol and sirtuins.
— Jord
Choosing a resveratrol supplement
If you decide to use resveratrol after speaking to your doctor or pharmacist, check these points on any label:
- Dose per capsule and servings per pack, so that you can compare with the doses studied.
- Purity testing, stated by the maker.
- Vegan and allergen details, if relevant.
- Subscription or one-time purchase, so that you can stop easily.
Vivetus® Resveratrol is available as 30 capsules of 500 mg. You can see the full range on the resveratrol collection page. Orders over €50 ship free, and international shipping and subscription options are available.
What good blood sugar habits look like
The evidence for lifestyle is far stronger than the evidence for any single supplement. Voedingscentrum’s guidance centres on eating according to the Schijf van Vijf. A supplement should not displace those basics. Regular check-ups, an agreed HbA1c target and a plan with your care team come first.
If you are buying for an older relative, the same rule applies. Ask the GP or pharmacist whether any new supplement fits with their medicines, and keep a list of what they take.
FAQ
Does resveratrol lower blood sugar?
Some pooled analyses report lower fasting glucose in people with type 2 diabetes. The Cochrane review, which looked at three small trials, found neutral results and very low certainty. In adults without diabetes, trials have mostly found no change.
Does resveratrol improve insulin sensitivity?
A Dutch trial of 150 mg a day for 6 months in overweight adults found no difference from placebo on the Matsuda index. A 12-week trial in postmenopausal women also found no improvement. Meta-analyses suggest any effect is limited to people with diabetes, and even there the trials differ widely.
What dose of resveratrol has been studied for blood sugar?
Trials have used anything from 10 mg to 1,000 mg a day, for periods from 4 weeks to 6 months. A 2022 review concluded that evidence was not enough to recommend a therapeutic dose. Your doctor or pharmacist can advise on what suits your situation.
Is it safe to take resveratrol with diabetes medicines?
Speak to your GP or pharmacist first. NCCIH warns of interactions with some medicines, especially anticoagulant and antiplatelet drugs, and a supplement that changes glucose could affect how your treatment works. Do not change or stop medicines on your own.
Can resveratrol replace diabetes treatment?
No. Cochrane found insufficient evidence on both effect and safety in type 2 diabetes. Treatment and diet plans should be changed only with your care team.
Sources
- Cochrane: Resveratrol for adults with type 2 diabetes mellitus
- American Journal of Clinical Nutrition: Effect of resveratrol on glucose control and insulin sensitivity
- Efficacy and safety of resveratrol supplements on blood markers (2021)
- Influence of age and dose on the effect of resveratrol (2022)
- No effect of resveratrol supplementation after 6 months on insulin sensitivity (2020)
- Resveratrol supplementation does not improve metabolic function in nonobese women (2012)
- NCCIH: Type 2 diabetes and dietary supplements
- Voedingscentrum: Diabetes type 2